Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 506


[Atrial fibrillation and stroke].

Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D.

Tidsskr Nor Laegeforen. 2013 Aug 6;133(14):1453-7. doi: 10.4045/tidsskr.12.0850. Review. Norwegian.


Can we predict stroke in atrial fibrillation?

Lip GY.

Clin Cardiol. 2012 Jan;35 Suppl 1:21-7. doi: 10.1002/clc.20969. Review.


Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?

Chao TF, Liu CJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen TJ, Lip GY, Chen SA.

J Am Coll Cardiol. 2015 Feb 24;65(7):635-42. doi: 10.1016/j.jacc.2014.11.046.


The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis.

Xiong Q, Chen S, Senoo K, Proietti M, Hong K, Lip GY.

Int J Cardiol. 2015 Sep 15;195:237-42. doi: 10.1016/j.ijcard.2015.05.115. Epub 2015 May 21.


The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.

Thromb Haemost. 2012 Jun;107(6):1172-9. doi: 10.1160/TH12-03-0175. Epub 2012 Apr 3.


CHA2DS2-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.

Kim TH, Yang PS, Kim D, Yu HT, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B, Lip GYH.

Stroke. 2017 Nov;48(11):2984-2990. doi: 10.1161/STROKEAHA.117.018551. Epub 2017 Sep 22.


Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.

Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.

J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23.


Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.

Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.

Europace. 2014 Feb;16(2):195-201. doi: 10.1093/europace/eut244. Epub 2013 Sep 12.


Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.

Brandes A, Overgaard M, Plauborg L, Dehlendorff C, Lyck F, Peulicke J, Poulsen SV, Husted S.

Clin Cardiol. 2013 Jul;36(7):427-32. doi: 10.1002/clc.22133. Epub 2013 May 13.


Warfarin therapy for atrial fibrillation in general practice--is bleeding risk underestimated?

Bratland B, Hornnes MB.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):175-9. doi: 10.4045/tidsskr.13.0626. English, Norwegian.


Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

Jover E, Roldán V, Gallego P, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F.

Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. Epub 2012 May 18. English, Spanish.


Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.

Overvad TF, Larsen TB, Albertsen IE, Rasmussen LH, Lip GY.

Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1619-29. doi: 10.1586/14779072.2013.839214. Review.


Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.

Zhu WG, Xiong QM, Hong K.

Tex Heart Inst J. 2015 Feb 1;42(1):6-15. doi: 10.14503/THIJ-14-4353. eCollection 2015 Feb. Review.


The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.

Barnes GD, Gu X, Haymart B, Kline-Rogers E, Almany S, Kozlowski J, Besley D, Krol GD, Froehlich JB, Kaatz S.

Thromb Res. 2014 Aug;134(2):294-9. doi: 10.1016/j.thromres.2014.05.034. Epub 2014 Jun 2.


Advances in stroke prevention in atrial fibrillation: enhanced risk stratification combined with the newer oral anticoagulants.

Verheugt FW.

Clin Cardiol. 2013 Jun;36(6):312-22. doi: 10.1002/clc.22122. Epub 2013 Apr 8. Review.


Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.

Marcucci M, Lip GY, Nieuwlaat R, Pisters R, Crijns HJ, Iorio A.

Am J Med. 2014 Oct;127(10):979-986.e2. doi: 10.1016/j.amjmed.2014.05.003. Epub 2014 May 13.


Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.

Lip GY, Skjøth F, Rasmussen LH, Larsen TB.

J Am Coll Cardiol. 2015 Apr 14;65(14):1385-94. doi: 10.1016/j.jacc.2015.01.044. Epub 2015 Mar 11.


Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.

Joundi RA, Cipriano LE, Sposato LA, Saposnik G; Stroke Outcomes Research Working Group.

Stroke. 2016 May;47(5):1364-7. doi: 10.1161/STROKEAHA.115.012609. Epub 2016 Mar 29. Review.

Supplemental Content

Support Center